Theranexus (EPA:ALTHX) | Finanzwire

Basculer en Français

10054	Companies
205246	Keywords
135492	Articles
108821	Press releases

Home
Companies
Theranexus

PRESS RELEASE

published on 12/17/2024 at 18:00, 1 year 3 months ago

THERANEXUS AND EXELTIS (INSUD PHARMA) ANNOUNCE LICENSING AGREEMENT TO COMMERCIALIZE THERANEXUS TX01 FOR TWO RARE NEUROLOGICAL DISORDERS
Theranexus and Exeltis sign license agreement for TX01, expanding treatment for rare neurological diseases. Exeltis to market TX01 across Europe and other regions

License Agreement Theranexus Neurological Diseases Exeltis TX01
BRIEF

published on 11/19/2024 at 18:05, 1 year 3 months ago

Theranexus presents positive results for the treatment of Batten disease CLN3

Clinical Trial Theranexus Batten-1 Batten Disease Visual Acuity
PRESS RELEASE

published on 11/19/2024 at 18:00, 1 year 3 months ago

Update on the Theranexus' Batten-1 project in CLN3 Batten's disease
Theranexus and BBDF present positive results of Batten-1 trial in CLN3 Batten disease patients, showing safety and efficacy of miglustat. Expanded use indicates potential in visual acuity stabilization

Theranexus BBDF Batten-1 Trial CLN3 Batten Disease Miglustat
BRIEF

published on 10/23/2024 at 18:05, 1 year 4 months ago

Theranexus Announces Its Cash Position as of September 30, 2024

Treasury Batten Disease Miglustat Research Tax Credit Industrial Partnerships
PRESS RELEASE

published on 10/23/2024 at 18:00, 1 year 4 months ago

THERANEXUS ANNOUNCES ITS CASH POSITION AS OF SEPTEMBER 30, 2024
Theranexus reports €1.9 million cash position as of September 30, 2024, with plans for product registrations and phase 3 trials in rare neurological diseases

Cash Position Biopharmaceutical Theranexus Rare Neurological Diseases Product Registrations
BRIEF

published on 10/17/2024 at 18:05, 1 year 5 months ago

Theranexus partners with Synerlab for a breakthrough in the treatment of Niemann-Pick C

Theranexus EMA Synerlab Miglustat Niemann-Pick C
PRESS RELEASE

published on 10/17/2024 at 18:00, 1 year 5 months ago

THERANEXUS JOINS UP WITH SYNERLAB TO PREPARE THE COMMERCIALIZATION OF ITS PEDIATRIC FORMULATION IN NIEMANN-PICK TYPE C DISEASE
Theranexus partners with Synerlab to produce oral solution of miglustat for Niemann-Pick type C disease, aiming for EMA approval and commercialization by 2026. Novel pediatric formulation Mig-OS provides new therapeutic option for NPC patients

Theranexus Synerlab Miglustat Niemann-Pick Type C Disease EMA Approval
BRIEF

published on 09/26/2024 at 18:05, 1 year 5 months ago

Theranexus announces its financial results for the first half of 2024

Financial Results Cost Reduction Biopharmaceutical Theranexus Batten-1
PRESS RELEASE

published on 09/26/2024 at 18:00, 1 year 5 months ago

THERANEXUS ANNOUNCES FIRST HALF 2024 FINANCIAL RESULTS
Theranexus reports cost reduction success and positive first half 2024 financial results, led by completion of Batten-1 clinical trial and operating grants

Financial Results Cost Reduction Clinical Trial Theranexus Batten-1
BRIEF

published on 07/11/2024 at 18:50, 1 year 8 months ago

Theranexus announces its cash flow as of June 30, 2024 and details the progress of Batten-1

Treasury Funding Theranexus Batten-1 Neurological Disease

Accesswire

Published on 03/19/2026 at 12:00, 31 minutes ago

Galway Metals Intersects 8.6 g/t Gold Over 15.0m Including 110.0 g/t Over 1.0m at Southwest Deposit
Published on 03/19/2026 at 12:00, 31 minutes ago

Gamma Resources Announces Debt Settlement and Insider Warrant Exercises
Published on 03/19/2026 at 12:00, 31 minutes ago

Prince Silver Delivers Further Strong Drill Results, Highlighted by 7.62 Metres of 230 G/T Silver, 10.78% Manganese, 1.87% Lead, 2.54% Zinc and 0.58 G/T Gold
Published on 03/19/2026 at 12:00, 31 minutes ago

Athena Gold Provides Exploration Update From Excelsior Springs, Nevada
Published on 03/19/2026 at 12:00, 31 minutes ago

Aclara Inaugurates Rare Earth Separation Pilot Plant in Virginia Tech to Advance U.S. Supply of Heavy Rare Earths

View all ACCESSWIRE

EQS Group

Published on 03/19/2026 at 12:10, 21 minutes ago

ZPMC Completes First Emissions Rights Transaction in Shanghai
Published on 03/19/2026 at 12:05, 26 minutes ago

CD&R Expands Climate Leadership Program to Europe with Imperial College Business School and Extends Columbia University Partnership in the U.S. for Second Year
Published on 03/19/2026 at 12:05, 26 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 03/19/2026 at 12:00, 30 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 03/19/2026 at 12:00, 31 minutes ago

PT Danantara Investment Management opens DPT registration for PSEL partners

Les Echos

Published on 03/19/2026 at 08:45, 3 hours 46 minutes ago

Deezer and Sonos renew and expand long-term collaboration
Published on 03/19/2026 at 07:00, 5 hours 31 minutes ago

bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 5 hours 31 minutes ago

2025 Annual results and new strategic signature
Published on 03/18/2026 at 19:41, 16 hours 50 minutes ago

Covivio - Conditions of availability of the 2025 Universal Registration Document
Published on 03/18/2026 at 18:00, 18 hours 31 minutes ago

Deezer achieves profitability in FY25 as strategy delivers tangible results

View all LES ECHOS COMFI WIRE